Lund University (LU)

Associate Researcher in Chemical Biology

Lund University (LU)

Lund, Sweden

Institutionen för experimentell medicinsk vetenskap

Lund University was founded in 1666 and is repeatedly ranked among the world’s top 100 universities. The University has 40 000 students and 7 600 staff based in Lund, Helsingborg and Malmö. We are united in our efforts to understand, explain and improve our world and the human condition.

The Faculty of Medicine is a part of Lund University, and is responsible for education and research within medicine and healthcare. Our academic programs are closely linked with the healthcare system and are firmly anchored in the faculty’s strong research tradition. Our research spans a broad field within experimental preclinical research, near-patient clinical research and health sciences research. The Faculty of Medicine, with its 1,800 employees and 2,700 students in Lund and Malmö, is a knowledge-intensive meeting place for students, teachers and researchers from all over the world.
We are looking for a driven assistant researcher. The employment is 100% for 2 years with the desired date of admission 2020-02-01 or as agreed. A probation period may be applied.

The research group

The Chemical Biology & Therapeutics is a multidisciplinary team at Lund University and University of Gothenburg that explore new therapeutic strategies using organic/medicinal chemistry, in-vivo/in-vitro biology, and applied physics. The lab was recently awarded funding for studying in-vivo assembled therapeutics and for an Electronic Neuropharma project (e-NeuroPharma), aiming to address CNS disorders by self-assembled therapeutics. In the e-Neuropharma effort, we will develop self-organizing molecular systems that exert both pharmaceutical activity and electrical functionality to explore new therapeutics for neurodegenerative diseases. e-Neuropharma is a collaboration with the organic bioelectronic team at Linköping University and Chalmers Tekniska Högskola.

Work duties

The associate researcher will essentially carry out research at Lund University. The primary focus will be analyzing self-organized therapeutics targeting CNS/PNS in animal models, preferentially in zebrafish, but also in other models e.g., insects (locust) and organoids.



PhD degree in biology, neuroscience, or equivalent Documented experience of electrophysiology, preferably using microelectrodes in vitro, in vivo, or both

The Chemical Biology & Therapeutics lab is a small multidisciplinary team, we are looking for a team member that is a strong team player and someone who’s not afraid for diverse work assignments and at the same time is an expert, the main driver, and knowledge sharer within their own field of expertise.

Able to work independently, have excellent communication skills and have the ability to collaborate with people.

Research at the Chemical Biology & Therapeutics Laboratory and collaborators is carried out predominantly in English, excellent English (speaking, writing) is therefore a requirement for the position.

Desirable qualifications

-Practical experience of handling zebrafishes in experimental situations
-Practical experience of microinjections
-Practical experience of fluorescence microscopy
-Practical experience of working with fluorescent markers and immunofluorescence methods
-Good knowledge of neurobiology (fish neuroanatomy) and general fish anatomy

Lund University welcomes applicants with diverse backgrounds and experiences. We regard gender equality and diversity as a strength and an asset. We kindly decline all sales and marketing contacts.

To apply, please click the button “Login and apply” Submit you CV and motivational letter.

Type of employment Temporary position longer than 6 months
Contract type Full time
First day of employment Enligt överenskommelse
Salary Månadslön
Number of positions 1
Working hours 100 %
City Lund
County Skåne län
Country Sweden

Roger Olsson, forkargruppchef, 046-2220000
Maria Palmkron, personalsamordnare, 046-2220000

Please apply via recruiter’s website.

Quote Reference: PA2019/3828